Relay Therapeutics chief authorized officer sells $1,309 in inventory

Brian Adams, the Chief Authorized Officer of Relay Therapeutics, Inc. (NASDAQ:RLAY), a biotech firm with a market capitalization of $688 million, reported promoting 299 shares of the corporate’s widespread inventory on December 27, based on a latest SEC submitting. The…